THC range is the middle half of 101 public lab tests of Pink Rozay flower (2020–2022). Source: Cannlytics lab results, CC BY 4.0.
Pink Rozay is an indica variety. The effects people mention most are feeling aroused, relaxed and sleepy.
Public lab results give a good picture of its strength: 101 flower samples tested between 2020 and 2022 came in at a median of 19.2% total THC (the middle half ranged from 17.4% to 22.1%). CBD is typically negligible (under 0.5%). That is in line with most flower on dispensary shelves. Potency varies by grower and batch, so always check the label.
In lab tests its dominant terpene is myrcene, followed by caryophyllene and pinene. Myrcene is known for earthy, musky notes with a ripe-fruit edge, while caryophyllene adds black pepper and warm spice. Total terpene content measured a median of 1.4%. Consumers most often describe the flavour as rose, berry and flowery.
Beyond feeling aroused, reviewers also mention feeling euphoric and tingly. Some consumers say they reach for it when dealing with anxiety, stress and depression. The side effects mentioned most are dizziness, headaches and paranoia. These are personal reports, not medical advice.
Our catalogue lists 1 product made with Pink Rozay, mostly flower and pre-rolls, from brands including Cookies Canada. Availability differs by state and store.
Pink Rozay is also a parent of Lychee.
Median share of flower weight in lab tests.
Matched on reported effects, terpenes and type.